My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 114

    1.

    What can be learnt from models of incidence rates?

    Colditz GA, Rosner BA.

    Breast Cancer Res. 2006;8(3):208. Epub 2006 Jun 6. Review.PMID: 16762045 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study.

    Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, Simon MS, Strom BL, Press MF, Folger SG, Burkman RT, Deapen D, Spirtas R, Ursin G.

    Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1723-30.PMID: 18628424 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Second primary breast cancer occurrence according to hormone receptor status.

    Kurian AW, McClure LA, John EM, Horn-Ross PL, Ford JM, Clarke CA.

    J Natl Cancer Inst. 2009 Aug 5;101(15):1058-65. Epub 2009 Jul 9.PMID: 19590058 [PubMed - indexed for MEDLINE]Related articles

    5.

    Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study.

    Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE.

    Am J Epidemiol. 2009 May 15;169(10):1251-9. Epub 2009 Mar 24.PMID: 19318616 [PubMed - indexed for MEDLINE]Related articles

    6.

    Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.

    Chen WY, Colditz GA.

    Nat Clin Pract Oncol. 2007 Jul;4(7):415-23. Review.PMID: 17597706 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lifestyle, genetic susceptibility and future trends of breast cancer in Korea.

    Yoo KY, Kim Y, Park SK, Kang D.

    Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):679-82.PMID: 17250452 [PubMed - indexed for MEDLINE]Related articles

    9.

    Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.

    Jemal A, Ward E, Thun MJ.

    Breast Cancer Res. 2007;9(3):R28.PMID: 17477859 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

    Glass AG, Lacey JV Jr, Carreon JD, Hoover RN.

    J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. Epub 2007 Jul 24.PMID: 17652280 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relationship between epidemiologic risk factors and breast cancer recurrence.

    Brewster AM, Do KA, Thompson PA, Hahn KM, Sahin AA, Cao Y, Stewart MM, Murray JL, Hortobagyi GN, Bondy ML.

    J Clin Oncol. 2007 Oct 1;25(28):4438-44. Epub 2007 Sep 4.PMID: 17785707 [PubMed - indexed for MEDLINE]Related articles

    13.

    Predicting risk of breast cancer in postmenopausal women by hormone receptor status.

    Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA; Women's Health Initiative Investigators.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. Epub 2007 Nov 13.PMID: 18000216 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.

    Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.

    Arch Intern Med. 2006 Dec 11-25;166(22):2478-83.PMID: 17159013 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk.

    Rebbeck TR, Troxel AB, Norman S, Bunin G, DeMichele A, Schinnar R, Berlin JA, Strom BL.

    Am J Epidemiol. 2007 Dec 15;166(12):1392-9. Epub 2007 Sep 7. Erratum in: Am J Epidemiol. 2008 Apr 1;167(7):888. PMID: 17827444 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.

    Suzuki R, Orsini N, Saji S, Key TJ, Wolk A.

    Int J Cancer. 2009 Feb 1;124(3):698-712.PMID: 18988226 [PubMed - indexed for MEDLINE]Related articles

    18.

    Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.

    Liang J, Chen P, Hu Z, Zhou X, Chen L, Li M, Wang Y, Tang J, Wang H, Shen H.

    Carcinogenesis. 2008 Dec;29(12):2341-6. Epub 2008 Oct 8.PMID: 18845558 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

    Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.PMID: 17164374 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Relationship between age maximum height is attained, age at menarche, and age at first full-term birth and breast cancer risk.

    Li CI, Littman AJ, White E.

    Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2144-9.PMID: 17932363 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk